article thumbnail

NHC 2025 Notice of Benefit and Payment Parameters (NBPP) Comments

Putting Patients First Blog

NHC 2025 Notice of Benefit and Payment Parameters (NBPP) Comments January 16, 2024 Allen Pinn, Coordinator, Policy The National Health Council (NHC) submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding the 2025 Notice of Benefit and Payment Parameters (NBPP) on January 8.

article thumbnail

NHC Comments on Draft CY 2025 Part D Redesign Program Instructions

Putting Patients First Blog

These guidelines should encompass rigorous scrutiny of the impact of the Manufacturer Discount Program on formulary decisions and UM practices, ensuring they support broad access to essential medications within the newly defined standard Part D benefit structure as outlined in the Draft CY 2025 Part D Redesign Program Instructions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NHC Comments on Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies

Putting Patients First Blog

However, we urge CMS to consider the following recommendations to ensure the 2025 policies further align with patient-centered care. The NHC recommends clear communication to beneficiaries about these changes and robust support systems to address any issues that may arise during the transition.

article thumbnail

Three-year patent strategy for greater medicine access announced

European Pharmaceutical Review

A new strategy for 2023-2025 by the Medicines Patent Pool (MPP) aims to reduce access inequities, by improving the availability and affordability of health products in low- and middle-income countries (LMICs). Part of the plan includes enabling 30 million people to access MPP-licensed products each year by 2025.

article thumbnail

A Recap of HLC 2024

Putting Patients First Blog

A Recap of HLC 2024 March 14, 2024 By: Bhriana Onuoha, Senior Manager, Communications Last month, over 150 patient organizations, partners of patient organizations, business and industry representatives, and thought leaders networked in the sunny desert of Scottsdale, AZ, for the National Health Council’s (NHC’s) 2024 Health Leadership Conference.

article thumbnail

NHC’s comments in response to the 2025 Notice of Benefit and Payment Parameters (NBPP)

Putting Patients First Blog

Other members include health-related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses and organizations representing biopharmaceuticals, devices, diagnostics, generics, and payers. The following is an overview of the NHC’s comments on proposals in the 2025 NBPP.

article thumbnail

Moderna and UK government sign deal to establish mRNA facility

Pharmaceutical Technology

Planned to be operational by 2025, the construction of the facility is anticipated to begin early next year. To back the UK in its international efforts as part of the country’s “100 Days Mission” to lower the future pandemics’ impact, the MITC would offer direct access to pandemic response expertise.

Vaccines 140